9th Imaging in Cancer Drug Development

-

Join SMI at the anticipated 9th annual Imaging in Cancer Drug Development conference in March 2013 that will be the ultimate opportunity to witness presentations on the current developments surrounding oncology, pre-clinical & clinical imaging, technical innovations and advancements, imaging biomarkers in cancer drug development and the future of imaging.

With a reputation for attracting the industry’s leading figures, this year's agenda offers an unmatched opportunity for debate and resolution of key challenges and current advances in oncology imaging.

KEY TOPICS FOR 2013 INCLUDE:

• Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts
• Novel target identification and lead discovery in preclinical biomarkers and radiochemistry
• Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy
• Overcoming challenges in nuclear tracers for multiscale imaging in oncology
• Current application of PET/SPET modalities and a review of PFS (progression-free survival)
• Practical tools for business expansion in the current economic climate

Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

13 Mar 2013



All Upcoming Events
1 2 3 Next 
Microscopy & Microanalysis2 Aug 2015
WMIC 20152 Sep 2015
World Drug Safety Congress Europe8 Sep 2015
MSACL 2015 EU8 Sep 2015
ASHG 20156 Oct 2015
Neuroscience 201517 Oct 2015
BioData World Congress21 Oct 2015
AAPS 201525 Oct 2015
Medica 201516 Nov 2015
ASCB 201512 Dec 2015

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement